Zhang Fuxing, Liu Guoqing, Dong Rui, Gao Lei, Lu Weichen, Gao Lianxia, Zhao Zhongkuo, Lu Fei, Liu Mulin
Department of Gastrointestinal Surgery, First Affiliated Hospital of Bengbu Medical College, Bengbu 233000, China.
Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, China.
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Dec 20;44(12):2421-2433. doi: 10.12122/j.issn.1673-4254.2024.12.19.
To investigate the expression of cartilage acidic protein 1 (CRTAC1) in gastric cancer (GC) and its effect on biological behaviors and immune cell infiltration of GC.
Transcriptomic, GO and KEGG analyses were conducted to investigate the association of CRTAC1 expression with prognosis of GC patients and its involvement in cell function and signaling pathways. ESTIMATE algorithm was used to analyze the effect of CRTAC1 expression on the tumor microenvironment and the tumor mutation load. In two GC cell clines (HGC-27 and MKN-74), CCK8, EdU and clone formation assays, flow cytometry, and Hoechst staining were used to examine the effects of CRTAC1 knockdown on cell proliferation, cell cycle changes and apoptosis. Wound healing assay, Transwell assay, and Western blotting were performed to analyze the effect of CRTAC1 knockdown on GC cell migration and the underlying mechanism.
Bioinformatics analysis showed significantly higher expression of CRTAC1 in GC tissues than in adjacent tissues (<0.05). Age and tumor stage were both prognostic risk factors in GC patients with high CRTAC1 expression (<0.001). Analysis using ESTIMATE algorithm showed that CRTAC1 expression increased immune cell infiltration and decreased tumor mutational load in GC (<0.001). In HGC-27 and MKN-74 cells, CRTAC1 knockdown significantly inhibited cell proliferation and migration and promoted cell apoptosis. Western blotting demonstrated that CRTAC1 knockdown significantly increased E-cadherin expression and reduced the expression levels of vimentin, p-PI3K, AKT2, p-AKT and p-mTOR in GC cells.
High expression of CRTAC1 in GC tissues affects immunotherapeutic efficacy and prognosis of the patients, possibly by promoting epithelial-mesenchymal transition modulating tumor mutational load, tumor microenvironment, and the PI3K/AKT signaling pathway.
探讨软骨酸性蛋白1(CRTAC1)在胃癌(GC)中的表达及其对GC生物学行为和免疫细胞浸润的影响。
进行转录组学、基因本体论(GO)和京都基因与基因组百科全书(KEGG)分析,以研究CRTAC1表达与GC患者预后的关联及其在细胞功能和信号通路中的作用。使用ESTIMATE算法分析CRTAC1表达对肿瘤微环境和肿瘤突变负荷的影响。在两种GC细胞系(HGC - 27和MKN - 74)中,采用细胞计数试剂盒8(CCK8)、5 - 乙炔基-2'-脱氧尿苷(EdU)和克隆形成试验、流式细胞术以及Hoechst染色来检测CRTAC1基因敲低对细胞增殖、细胞周期变化和凋亡的影响。进行伤口愈合试验、Transwell试验和蛋白质免疫印迹法,以分析CRTAC1基因敲低对GC细胞迁移的影响及其潜在机制。
生物信息学分析显示,CRTAC1在GC组织中的表达显著高于相邻组织(P<0.05)。年龄和肿瘤分期都是CRTAC1高表达的GC患者的预后危险因素(P<0.001)。使用ESTIMATE算法分析表明,CRTAC1表达增加了GC中的免疫细胞浸润并降低了肿瘤突变负荷(P<0.001)。在HGC - 27和MKN - 74细胞中,CRTAC1基因敲低显著抑制细胞增殖和迁移并促进细胞凋亡。蛋白质免疫印迹法表明,CRTAC1基因敲低显著增加了GC细胞中E - 钙黏蛋白的表达,并降低了波形蛋白、磷酸化磷脂酰肌醇-3激酶(p - PI3K)、蛋白激酶B2(AKT2)、磷酸化蛋白激酶B(p - AKT)和磷酸化哺乳动物雷帕霉素靶蛋白(p - mTOR)的表达水平。
GC组织中CRTAC1的高表达可能通过促进上皮 - 间质转化、调节肿瘤突变负荷、肿瘤微环境和PI3K/AKT信号通路来影响患者的免疫治疗疗效和预后。